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Role of sodium in hemodialysis. Sodium chloride is the most composition. In reality, dialysate is a plasma water-like
abundant salt in extracellular fluid. In normal individuals, the solution capable of both removing toxins and delivering
tonicity exerted by dissolved sodium chloride determines solute and solvent to the patient. Early dialysis physiciansplasma osmolality and indirectly determines intracellular tonic-
identified the capacity of dialysate to intoxicate patientsity and cell volume. Uremic patients retain nitrogenous wastes
through the unintentional delivery of toxic trace elementsand have an elevated plasma osmolality. While urea exhibits
osmotic activity in serum, no sustained gradient can be estab- and mistaken compounding [1–3]. Similarly, depletion
lished across cell boundaries because it readily diffuses through syndromes could be precipitated by dialysate devoid of
cell membranes. Thus, sodium remains the major indicator of critical plasma constituents (hypoglycemia). In reality,body tonicity and determines the distribution of water across
dialysate is the only drug used by all dialysis patientsthe intracellular–extracellular boundary, subsequent cell vol-
and is critical to safe, effective extracorporeal renal re-ume, thirst, and, among patients with renal insufficiency, sys-
temic blood pressure. As a result of highly conserved plasma placement [4, 5]. It is understandable, therefore, that
tonicity control systems, uremic subjects demonstrate remark- early physicians formulated dialysate specifically to meet
able stability of their serum sodium. Dialysate is a synthetic
the unique needs of their patients and the technologyinterstitial fluid capable of reconstituting extracellular fluid
available to them [6].composition through urea extraction and extremely efficient
solute and solvent (salt and water) transfer to the patient. Advanced renal failure typically results in sodium re-
Subtle transdialyzer gradients deliver and remove large quanti- tention [7–10] and hypertension [11–14]. Early dialysis
ties of trace elements, solvent, and solute to patients, creating systems used relatively small surface area dialyzers, im-
a variety of dialysis “disequilibrium” syndromes manifest as
permeate cellulosic membranes, and open dialysate res-cellular and systemic distress. Every dialysis patient uses dialy-
ervoirs. Dialyses of the era were prolonged, lasting 8 tosate, and the most abundant chemicals in dialysate are salt and
24 hours, and the delivery systems were incapable ofwater. Despite its universal use, no consensus on dialysate
composition or tonicity exists. This can only be explained if regulated hydrostatic “ultrafiltration.” Thus, in the 1960s
we believe that dialysate composition is best determined by and 1970s, dialysis prescriptions required that interdia-
matching unique dialysis delivery system characteristics to spe-
lytic salt and water accumulations be removed by diffu-cific patient requirements. Such a paradigm treats dialysate as
sion and osmosis rather than by regulated hydrostatica drug and the dialysis system as a delivery device. Understand-
transmembrane pressure “ultrafiltration.” Diet prescrip-ing the therapeutic and toxic profiles of this drug (dialysate)
and its delivery device (the dialyzer) is important to safe, effec- tions limited sodium intake to 45 to 90 mmol/day and
tive, goal-directed modifications of therapy. This article ex- fluid to less than 1 L/day. In order to remove the salt
plores some of the historical rationale behind choosing specific and water that accumulated between dialyses, early in-dialysate tonicities.
vestigators used dextrose containing hyponatremic dialy-
sate to create osmotic and diffusive transmembrane gra-
dients. Dialysate compounded with a sodium content ofDialysis is a complex, albeit empiric, therapy. Typically
approximately 126 mEq/L permitted removal of the 250envisioned as a washing or cleansing process, dialysis
to 450 mmol of salt and 5 to 8 L of water ingested weeklyuses dialysate, a synthetic plasma water component, to
[15]. This hyponatremic dialysate controlled blood pres-remove soluble wastes from the blood. The ideal dialy-
sure in 70 to 90% of patients, suppressed thirst, andsate contains all of the elements of normal plasma and
helped control interdialytic weight gain [16–18].is devoid of any excesses that accumulate during uremia.
In the 1970s, improved dialyzer construction and deliv-This permits soluble wastes to diffuse from the patient
ery system design permitted increasing dialysis efficiencyinto the dialysate and normalizes the patient’s plasma
and hydrostatic transmembrane pressure-driven “ultra-
filtration.” Physicians began to report a dialysis precipi-
tated, potentially fatal “disequilibrium” syndrome. TheKey words: salt, plasma osmolality, cell volume, intracellular tonicity,
dialysate, renal replacement therapy. manifestations of “dialysis disequilibrium” included fa-
tigue, nausea, lethargy, headache, muscle cramps, andÓ 2000 by the International Society of Nephrology
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occasionally intracranial hypertension complicated by maximize the hemodynamic stability and minimize the
“disequilibrium” of these acutely ill dialysis patients, weseizures and death [19]. As the biochemical efficiency of
dialysis, increased “dialysis disequilibrium” became a produced a “eunatremic,” high-calcium, bicarbonate di-
alysate with a sodium content of 140 mEq/L and a cal-more prominent concern, and by the late 1970s, “dialysis
discomfort” was an anticipated consequence of dialysis. cium of 1.75 mmol/L. During testing, we found that stable
maintenance hemodialysis patients preferred and vocif-The “discomfort” and “disequilibrium” syndromes were
variously attributed to electrolyte imbalance, osmotic erously requested bicarbonate dialysate because they be-
lieved it improved dialysis comfort. We also discovereddisequilibria, tissue hypoxia, acetate intolerance, and cy-
tokine stimulation. The most serious problem, brain that patients blinded to the dialysate composition could
not reliably distinguish between bicarbonate dialysateedema, was believed to be the result of an acute reduc-
tion in serum urea or osmolality and could be amelio- and a specially prepared 140 mEq/L “high”-sodium, ace-
tate-based dialysate. Additional experiences suggestedrated by limiting dialysis efficiency or infusing osmotic
agents [19–21]. that dialysate tonicity played a substantial role in the
“superior hemodynamic stability” of bicarbonate dialysisThe advent of blood pumps, durable large surface area
dialyzers, and negative-pressure dialysis delivery systems [29–35]. Presumably, as blood is dialyzed, plasma osmo-
lality drops from approximately 310 mOsm/L to approxi-dramatically altered hemodialysis. Hydrostatic ultrafiltra-
tion became a safe effective reality. By 1980, mechanical mately 290 mOsm/L. When reinfused in the patient whose
osmolality is 310 mOsm/L, the osmotic gradient is dissi-hydrostatic fluid removal could exceed 1 L/hour, and
osmotic convective forces were no longer required. Si- pated when water moves out of the plasma and into
the interstitial and intracellular spaces [15]. This processmultaneously, the National Cooperative Dialysis Study
revealed that “short” dialysis could achieve biochemical reduces plasma volume and incites intracellular edema
even in the absence of ultrafiltration. Recurrent descrip-adequacy [22]. Combining durable large surface area
dialyzers with “ultrafiltration”-regulated dialysis delivery tions of improved dialysis comfort, reduced disequilib-
rium, and better ultrafiltration tolerance made “high”-systems would theoretically permit uremia control and
salt and water regulation during “short,” efficient hemodi- sodium, bicarbonate-based dialysate a requisite for
“rapid,” “high-efficiency” hemodialysis therapy [36–39].alysis. Furthermore, because hydrostatic ultrafiltration
was both potent and flexible, dietary salt and water re- Changes in plasma osmolarity were once thought to
be the primary determinants of both dialysis “disequilib-strictions could be relaxed. Technology had achieved a
true breakthrough. Dietary privations could be relieved, rium” and hemodynamic instability [40]. If dialysis “dis-
equilibrium” and “discomfort” are the result of cellularand dialysis treatment times decreased from six to eight
hours to four to five hours thrice weekly! These events osmotic distress, then abolishing the translocation of water
from the extracellular to the intracellular space shouldwould greatly facilitate patient rehabilitation.
By 1980, “hypotonic dialysate” was no longer crucial obviate the disorder; a number of osmotic substances,
including mannitol, glycerol, urea, and sodium, success-to dialysis salt and water removal, and because “high”
sodium dialysate diminished the severity of “dialysis dis- fully achieved this goal [19, 25]. Alternatively, the symp-
toms of dialysis “disequilibrium” are reminiscent of “waterequilibrium” [21], dialysate sodium concentrations drifted
upward from 126 mmol/L to a more physiologic range intoxication,” and the syndrome itself became obscure
with the introduction of more physiologic dialysates [41].of 130 to 135 mmol/L [15, 16]. In this era of rapid, “short”
dialysis, the incidences of “dialysis discomfort” were sub- Agents that restore plasma volume and tissue perfusion
relieve dialysis “discomfort.” A serum sodium changestantial [23]. Hypotension, nausea, vomiting, cephalgia,
and muscle cramps occurred in 15 to 70% of all dialysis of 1 mEq/L is the osmotic equivalent of a 6 mg/dL change
in blood urea nitrogen (2 mmol urea) or the oncoticsessions and were so frequent that they became virtually
synonymous with the hemodialysis process [24, 25]. It gradient produced by 10 g/dL of serum protein [42].
Thus, between 1980 and 1995, as the average dialysatewas proposed that the large surface area dialyzers needed
for “short” dialysis removed bicarbonate and delivered sodium increased from approximately 132 mmol to the
present day 140 to 145 mmol, we eliminated an osmoticacetate to patients at rates exceeding their metabolic
capacity. This presumably resulted in acetate accumula- shift equivalent to a 50 to 70 mg/dL fall in blood urea
nitrogen (14 to 26 mmol urea) and greatly diminishedtion, symptomatic intoxication, and “discomfort” with
hypotension, headache, nausea, vomiting, dizziness, and the likelihood of significant cerebral edema or “disequi-
librium.” Additionally, it is likely that dialysis-inducedmuscle cramps [24, 26]. Following reports of lessened
hypoxia and improved vascular stability, bicarbonate con- plasma volume depletion and hemodynamic instability
are not the result of urea-induced osmotic disequilibriacentrates for single-pass dialysis proportioning systems
were developed [26–28]. nor of aberrant vascular tone, but are a function of the
dialysate to plasma tonicity gradient and the ultrafiltra-In the early 1980s, the University of Iowa was primarily
an in-hospital acute dialysis provider. In an attempt to tion/plasma refilling paradigm. It is tonicity and not urea
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Fig. 2. Midweek serum sodium for 12 consecutive months in 10 nondia-
betic dialysis patients. The box and whiskers plot represents the mean
(h), 25th and 75th percentile (box), and 10th and 90th percentile (whisk-
Fig. 1. Incidence of complications noted during several dialysis proto- ers) sodium values for each individual. The group mean is 138 6 3.4
cols assessing the benefits of acetate and bicarbonate buffer and 140 mEq/L and is represented by the straight line. Each patient has a
mmol and 145 mmol sodium dialysate during hemodialysis [36]. Stan- relatively fixed and stable serum tonicity with a narrow range of varia-
dard dialysis lasted approximately four hours, and rapid therapy lasted tion (62%). These patients use a bicarbonate dialysate with a delivered
2.75 hours. Mean weight loss was 2.0 kg for standard dialysis using a sodium concentration of 140 6 2 mmol/L measured by indirect potenti-
140 mmol sodium 40 mmol acetate dialysate and 1.6 kg using the same ometry and had a wide range of interdialytic weight gains (0.2 kg to
acetate dialysate for 2.75 hours. Bicarbonate dialyses achieved weight 5.6 kg).
losses of 1.9 kg using a 140 mmol sodium and 35 mmol bicarbonate
dialysate and 2.4 kg using a 145 mmol sodium 35 mmol bicarbonate
dialysate for a 2.75-hour dialysis. Predialysis blood pressure increased
in the “short, high-efficiency” treatments unless ultrafiltration was in-
creased. There were fewer episodes of symptomatic hypotension using WHAT CONSTITUTES
bicarbonate dialysate. Ultrafiltration tolerance was improved by using
“HIGH”-SODIUM DIALYSATE?higher sodium dialysate.
Sodium chloride is the predominant extracellular salt
and the primary determinant of plasma and hence intra-
cellular tonicity. While plasma volume is relatively elas-osmolality that determines water movement across cell
tic, plasma tonicity is highly conserved. When Gotch etmembranes to influence plasma refilling and subsequent
al changed dialysate sodium from a low of 132 mEq/Lintradialysis comfort [23, 24, 25, 41, 43–46].
to a high of 146 mEq/L, he found that the predialysisWhat are the benefits of “high”-sodium dialysate?
serum sodium of his patients remained constant [25].High-sodium dialysate minimizes dialysis disequilibrium,
Similarly, Figure 2 illustrates that over a one-year inter-and by abstracting water from the intracellular into the
val, nondiabetic dialysis patients have extremely littleinterstitial and plasma compartments reduces the fre-
variation in their serum tonicity. While the mean predial-quency and severity of dialysis hypotension. By avoiding
ysis serum sodium of these patients is 138 6 3.4 mEq/L,tissue hypoperfusion, “high”-sodium dialysate ameliorates
individual values vary from 132 to 144 mEq/L. However,the common manifestations of dialysis “discomfort,” in-
the predialysis sodium of any individual patient variescluding nausea, vomiting, headache, chest pain, hypoten-
by less than 2 mEq/L from month to month, a degreesion, and perhaps cramps [29, 44]. In most reports, “short,”
of variability within the laboratory’s analytical error (rel-“high-efficiency,” and “ultra-high-efficiency” dialysis with
ative error 6 1%). Furthermore, when these patientsa “high”-sodium, bicarbonate-based dialysate actually
dialyze with a 140 mEq/L sodium dialysate, their serumproduces less intradialysis discomfort and hypotension
sodium increases. Figure 3 reveals that the predialysisthan does standard therapy [23, 36–38]. “Short,” “high-
to postdialysis sodium increases 2.3 6 3.6 mEq/L butefficiency” dialysis with “high”-sodium dialysate, how-
can vary from 22.0 to 8.0 mEq/L, and in at least oneever, is regularly associated with an increased interdia-
patient, the postdialysis serum sodium concentration waslytic weight gain and, as Figure 1 illustrates, an increased
145 mEq/L [47]. This suggests that while dialysis success-incidence of predialysis hypertension [23, 24, 36, 38, 47].
fully removes the patient’s interdialytic weight gain (orIt has also been proposed that the improved intradialysis
water intake 5 water removal), it fails to restore saltcomfort of “short,” “high-efficiency” therapy may be
partially offset by greater interdialytic distress [23]. balance because the interdialytic dietary sodium is in-
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maximum disorder. Since only infinitely dilute solutions
exhibit “ideal behavior,” chemists describe reactions by
modifying the chemical concentration (c) with a “fudge
factor” or activity coefficient (f) to derive an activity or
apparent concentration (a) [51, 52]. This recognizes that
not all the sodium ions present are immediately available
to enter into a reaction and that only free noncomplexed
ions are electrochemically active. Furthermore, sodium
activity (a) changes with the composition and temperature
of the solution. Thus f, the activity coefficient, changes
when the solution composition is altered. Changing solu-
tion pH or adding other ions, such as carbonate, bicar-
bonate, or phosphate, effectively lowers the number of
free, noncomplexed sodium ions in solution and reduces
the activity and activity coefficient of sodium.Fig. 3. Patients using a dialysate sodium of 140 mmol/L have an in-
crease in their serum sodium during dialysis. This finding, combined
a 5 f 3 cwith the data in Figure 2, suggests that each patient has a unique
“osmostat” setting and will drink water to restore plasma tonicity to
activity 5 activity coefficient 3 concentrationsome nominal value. Thus, dialysis salt loading presumably leads to
excessive thirst and subsequent increased interdialytic weight gain.
Distinguishing between concentration and activity is par-
amount to understanding why patients fail to achieve
simultaneous salt and water balance during dialysis. Only
completely removed. Failure to achieve isonatric dialysis chemically active sodium is able to move across a dialysis
results in a tonicity increase equivalent to the unantici- membrane by diffusion, and it is the difference between
pated retention of 80 mmol of NaCl. How and why did the activity of sodium in the blood and the activity of
this happen? sodium in the dialysate that drives diffusion across the
dialysis membrane. Patients with a predialysis serum so-
dium concentration of 134 mEq/L can end treatmentSODIUM FLUXES ACROSS THE
with a serum sodium concentration of 144 mEq/L and aDIALYSIS MEMBRANE
postdialysis serum sodium activity of 148 mEq/L despiteThe physical characteristics determining diffusion and
using dialysate with a sodium concentration of 140 mEq/Lconvection across the dialyzer have been described. Sim-
[5, 49, 53–56].ply increasing the membrane surface area to achieve
There are substantial differences between the serumhigh efficiency does not produce discrepant solvent and
sodium concentration and activity. First, we need to ex-solute movement. Rather, the membrane’s intrinsic re-
amine the measurement process [51, 52, 54, 57]. If a litersistance to solute and solvent (water) flow and the con-
of blood is placed in a beaker, we can measure its sodiumcentration or activity gradients across the membrane are
content by burning or ashing the sample, dissolving thethe variables responsible for the relative transmembrane
ash in dilute hydrochloric acid, and performing emissionfluxes of salt and water [4, 25, 48–50].
flame spectroscopy to find a whole blood sodium content
of 84 mEq/L. If we then place 10 mL of blood into a
THE CONCENTRATION GRADIENT dialysis sac and suspend that sac in a liter of salt solution
containing 84 mmol of NaCl, we would be surprised toDialysate containing 140 mEq/L sodium reduces dial-
find the sac swell and even burst as fluid flows acrossysis discomfort, and because the sodium concentration
the membrane into the blood sample. This occurs be-is in the “normal” range, it is anticipated that isonatric
cause blood is a complex fluid in which 40% of thedialysis will be achieved. The classic thermodynamic law
volume is occupied by red cells devoid of sodium. Thus,of entropy predicts that as energy is put into a system,
all of the 84 mEq/L sodium concentration measured inmatter will disperse uniformly to a state of maximal
whole blood is present in the plasma, a volume of 0.6 Ldisorder. Diffusion is a manifestation of this disorder,
rather than 1.0 L. That means that the sodium contentand we expect dissolved substances to disperse uniformly
of plasma is 140 mEq/L, a value much higher than thatin solution. In reality, chemical systems are seldom ideal,
of our hypothetical dialysis solution, and thus, sodiumand dissolved substances interact with both solvent and
diffuses out of plasma into the bathing solution, whileother solutes. The sodium ions present in plasma interact
water diffuses down its activity gradient into the dialysiswith water and other dissolved materials, particularly
bag. The hematocrit in our dialysis bag does not changeproteins, bicarbonate, carbonate, and sulfate. These in-
teractions are a form of structure or failure to achieve appreciably because water is distributed across cell mem-
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branes entering both red cells and plasma, causing the THE DIALYSIS MEMBRANE
total blood volume to increase from 10 to 16 mL as the Using a semipermeable membrane for dialysis further
red cells swell. Sodium diffusion is not between blood complicates achieving balanced salt and water removal
and dialysate but between the salt-containing solutions: through isonatric dialysis. Based solely on activity mea-
plasma and dialysate. Had we spun down our blood surements, a 140 mEq/L “high”-sodium dialysate is hy-
sample and measured the sodium content of plasma, we ponatremic to the patients’ plasma water sodium of 147
would have reported a plasma sodium concentration of mEq/L, and sodium ions should diffuse from the patient
140 mEq/L. While sodium is restricted to moving be- into the dialysate, a prediction not fulfilled in vivo. Dial-
tween the plasma water and our dialysis solution, water ysis membranes are functional gels, and analogous to
freely traverses cell membranes and enters red cells caus- gel electrophoresis, the charge density of the membrane
ing them to swell and perhaps lyze as intracellular tonic- interacts with molecules as they move through its struc-
ity is diluted to equal that of the extracellular bathing ture. Under conditions of high ultrafiltration pressure
solution. (greater than 1 atmosphere) and high perfusate flow,
Alternatively, if we had measured the whole blood these membranes can function as reverse osmosis sys-
sodium with an ion-selective sodium electrode (direct tems. As charged ions approach the membrane, they are
potentiometry), we would have directly measured the repelled from the membrane gel and form a junctional
electrochemical activity of sodium in whole blood and layer that is relatively rich in ionic charge. This shell
found it to be equal that of plasma and plasma water. further repels ions and concentrates them in the perfu-
This measurement differs from the serum sodium con- sate producing a water-enriched ultrafiltrate. This is the
centration reported by emission flame spectrophotome- general principle behind reverse osmosis, and when
ter and the clinical laboratory because plasma contains charge dense, small pore membranes are used in high-
proteins and lipids, which occupy space in the plasma pressure settings, ion rejection can exceed 90%. Under
volume. Thus, if we ultracentrifuge plasma, >6% of in vitro conditions, the sieving effect for sodium ions
plasma is colloidal protein and lipid, and all 140 mEq of
across most dialysis membranes is negligible [54]. How-
sodium are in 0.94 L of plasma water. Thus, the plasma
ever, in vivo, as plasma approaches and enters the mem-water sodium concentration is 149 mEq/L. Indeed, any
brane, charged proteins are restricted from crossing thistime we add protein or lipid to a saline solution, we find
barrier and form a “shell” within the membrane. Thisthat sodium concentration measurements made by flame
shell is an electrochemical boundary that interacts withspectrophotometer decrease in proportion to the amount
other ions impeding their flow across the dialyzer toof protein added, yet direct activity measurement using
produce a water-enriched, ion-poor plasma ultrafiltrate.an ion-selective electrode remains constant [51]. Ion-
Furthermore, because electrical neutrality must be main-selective electrodes sense the electrochemical activity
tained, negatively charged proteins retained in the mem-of sodium ions and not the volume in which they are
brane and plasma water trap accompanying cations (so-dissolved. They can match activities but cannot deter-
dium, calcium, magnesium), causing them to be retainedmine concentrations (that is, the total mass of ions pres-
in the plasma water. Thus, salts are restrained from iso-ent in a sample).
tonic flow across the dialyzer membrane. This proteinThe laboratory method used to measure serum sodium
induced transport asymmetry is termed the Gibbs-Don-affects our perception of isonatric dialysate (that is, the
nan effect and results in the production of a hypotonicdialysate sodium concentration that results in no net
ultrafiltrate in which the sodium activity is less than thatsodium diffusion) [4, 54, 57]. When the laboratory uses
of the source plasma water [4, 25, 46, 50, 53, 55, 58, 59].flame photometry to measure plasma and dialysate so-
The overall membrane sieving or Donnan coefficientdium concentration, it underestimates the concentration
has been estimated to equal a sodium activity gradientof sodium in plasma water, and it would be preferable
of 25 to 210 mEq/L and is influenced by the compositionto convert these readings into activities to determine
of the dialysis membrane (total in vivo membrane sievingwhen the dialysate sodium activity equals the blood so-
coefficients, which include the Donnan coefficient, aredium activity. Since plasma is >94% water the mean
generally below 0.95). The Donnan effect predicts thatsodium content of plasma water for patients in Figures
isonatric dialysis will occur only if dialysate sodium activ-2 and 3 would be >147 mEq/L [(138 mEq/L plasma) 3
ity is 5 to 10 mmol less than the plasma water sodium(1 L plasma/0.94 L water) 5 147 mEq/L of water], and
activity. This offset is very close to the discrepancy be-the dialysate sodium concentration predicted to prevent
tween the flame spectrophotometer determined plasmadiffusive sodium transfer would be 147 mEq/L. (Using
sodium concentration and the plasma water sodium ac-plasma standards to calibrate ion-selective electrodes
tivity [46].performing indirect potentiometry adds further uncer-
What are “high” and “low” dialysate sodiums? Thetainty to the situation because dialysate sodium content
is overestimated [5]). term “low”-sodium dialysate refers to a dialysate sodium
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